Board Services: Network, Governance, Vision

With the life science and healthcare industries evolving at an incredible pace, it has never been more important to proactively develop the strength of your Board.

Clear vision and long term value


Truly independent Non-Executive Directors & Chairs bring a depth of experience in governance and genuine challenge to the Executive. They provide a clear vision of the future and enhance the long-term value of the company.


    Trusted Advisors

    As trusted advisors we learn about your strategy and ambition, review your Board and make recommendations for its evolution. Our advice helps you pre-position your Board for maximum impact and shareholder return whilst ensuring good governance and maintaining investor support.

    Powerful global network

    Our regular dialogue with senior industry figures, boards and investors gives us the network and insight to find the most appropriate board members. This network brings together a powerful global community of advisers, investors and Non-Executive Directors who understand the intricacies of the Life Sciences.

Board Services - Case Studies



Case Study

Chairman for Oxford Biomedica

Oxford Biomedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research, development and bioprocessing.

    “I have worked successfully with RSA in senior level recruitment in Life Sciences. I would recommend RSA for their approach to, and services for, executive search in the Life Sciences.”


    Sir Richard Sykes, Chairman of the Imperial College Healthcare NHS Trust, the UK Stem Cell Foundation, PDS Biotechnology Corp, the Royal Institution of Great Britain and NetScientific plc

    “I have known Nick Stephens and the RSA Group for many years, since my time as Head of GSK’s Center for Cognitive and Neurodegenerative Disorders in Biopolis, from 2005 to the end of 2009. I have known Nick and other members of the RSA Group to be talented, highly energetic and very effective. They are a group with Western roots, but a clear focus on Asia that predates that of most other life science recruitment firms. My interactions with them have been consistently positive.”


    Dr Tetsu Maruyama, Chief Scientific Advisor Dementia Discovery Fund & Former Corporate Officer / Former Senior VP, Head of Pharmaceutical Research Division Takeda Pharmaceutical Co., Ltd Fujisawa, Japan

Twitter

@theRSAgroup

Our Managing Partner, Eleanor Davies shares her thoughts in this #RSAViewpoints blog after joining a panel discussion at #PharmaIntegrates2021. Click the link below for some insightful reading.

https://thersagroup.com/future-of-pharma-working-practices/

Load More...